Navigation Links
Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
Date:1/26/2012

RALEIGH, N.C., Jan. 26, 2012 /PRNewswire/ -- Lend Lease is pleased to announce the appointment of Tom Chapman as Director of Operations for the Life Sciences group in the Atlantic Region.  Tom rejoined Lend Lease on January 4, 2012, and will be based out of the Raleigh, NC office, working closely with the regional office heads and business development teams in the South Atlantic offices. He will report directly to Steve Eberling, Senior Vice President, Principal In Charge, Life Sciences and Princeton.

Tom has been in the Design and Construction industry  for over 33 years and has focused his career specifically on the  Life Science sector for the last 22 years. During this time, Tom has worked for Day & Zimmerman / Life Sciences for 8 Years, Turner Construction for 6 Years and most recently Jacobs for the past 9 years.   Prior to working at Jacobs, Tom worked for the legacy Bovis Lend Lease business within the Global Life Sciences Group in the Princeton, NJ office. 

Tom has completed mechanical design and engineering, and engineering courses from Villanova and Temple Universities and received a master certificate PMP project management from Villanova University.  His numerous professional affiliations include International Society for Pharmaceutical Engineering (ISPE) Delaware Valley Chapter, Design Build Institute of America, Project Management Institute and the Drexel University Construction Management Advisory Committee.

About Lend Lease

Lend Lease is a leading international property and infrastructure group. Listed on the Australian Securities Exchange and with circa 17,000 employees worldwide, Lend Lease's capabilities span the property and infrastructure spectrum.

The Americas region headquarters is located in New York. In the Americas we offer project management & construction, public partnerships, public-private partnerships, development and asset & property management. Our expertise covers multiple sectors including arts & culture commercial office, education, government, healthcare, hotels & resorts, industrial, military housing communities, mixed-use, multi-site, pharmaceutical, senior living, solar, transportation and aviation.

We create innovative and sustainable property solutions, forging partnerships and delivering maximum benefits to clients, investors and communities.  Safety is our number one priority and Lend Lease is committed to operating Incident & Injury Free wherever we have a presence.

www.lendlease.com


'/>"/>
SOURCE Lend Lease
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
2. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
3. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
4. Verify Brand™ Announces the Release of VB Enterprise 4.0
5. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
6. ICD-10 Coding Knowledge Assessment Tool Released
7. Dyadic International Announces Date and Time of Third Quarter 2011 Financial Results Release and Conference Call
8. Minimally Invasive Devices, Inc. Announces Release of FloShield™ PLUS
9. Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
10. STAAR Surgical Announces Third Quarter 2011 Results Release Date and Conference Call
11. Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):